Estadístiques de Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
Visites totals
views | |
---|---|
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain | 99 |
Visites totals per mes
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 1 |
March 2025 | 1 |
April 2025 | 1 |
Visites al fitxer
views | |
---|---|
calleja-ejh-budg.pdf(legacy) | 60 |
calleja-ejh-budg.pdf | 52 |
Vistes principals per país
views | |
---|---|
United States | 49 |
Sweden | 17 |
Spain | 11 |
India | 4 |
Serbia | 4 |
Belgium | 2 |
Canada | 2 |
Ireland | 2 |
Iran | 2 |
Australia | 1 |
Germany | 1 |
United Kingdom | 1 |
Italy | 1 |
Oman | 1 |
Poland | 1 |
Visites principals per ciutat
views | |
---|---|
San Ramon | 9 |
Barcelona | 7 |
Menlo Park | 7 |
Ann Arbor | 3 |
Ashburn | 3 |
Girona | 3 |
Boardman | 2 |
Cambridge | 2 |
Dublin | 2 |
Fairfield | 2 |
Mountain View | 2 |
Redwood City | 2 |
Vijayawada | 2 |
Brooklyn | 1 |
Delhi | 1 |
Delta | 1 |
Genova | 1 |
Grojec | 1 |
Kissimmee | 1 |
Pinjarra | 1 |
Potsdam | 1 |
Rochester | 1 |
Thane | 1 |
Waterloo | 1 |